GB0204252D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB0204252D0
GB0204252D0 GBGB0204252.1A GB0204252A GB0204252D0 GB 0204252 D0 GB0204252 D0 GB 0204252D0 GB 0204252 A GB0204252 A GB 0204252A GB 0204252 D0 GB0204252 D0 GB 0204252D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0204252.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford Glycosciences UK Ltd
Original Assignee
Oxford Glycosciences UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford Glycosciences UK Ltd filed Critical Oxford Glycosciences UK Ltd
Priority to GBGB0204252.1A priority Critical patent/GB0204252D0/en
Publication of GB0204252D0 publication Critical patent/GB0204252D0/en
Priority to AU2003214367A priority patent/AU2003214367A1/en
Priority to PCT/GB2003/000752 priority patent/WO2003070239A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0204252.1A 2002-02-23 2002-02-23 Novel compounds Ceased GB0204252D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB0204252.1A GB0204252D0 (en) 2002-02-23 2002-02-23 Novel compounds
AU2003214367A AU2003214367A1 (en) 2002-02-23 2003-02-21 Benzylidene thiazolidinediones and their use as antimycotic agents
PCT/GB2003/000752 WO2003070239A1 (en) 2002-02-23 2003-02-21 Benzylidene thiazolidinediones and their use as antimycotic agents

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0204252.1A GB0204252D0 (en) 2002-02-23 2002-02-23 Novel compounds

Publications (1)

Publication Number Publication Date
GB0204252D0 true GB0204252D0 (en) 2002-04-10

Family

ID=9931614

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0204252.1A Ceased GB0204252D0 (en) 2002-02-23 2002-02-23 Novel compounds

Country Status (3)

Country Link
AU (1) AU2003214367A1 (en)
GB (1) GB0204252D0 (en)
WO (1) WO2003070239A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009249314A1 (en) 2008-05-20 2009-11-26 Merck Sharp & Dohme Corp. Efficient production of heterologous proteins using mannosyl transferase inhibitors
CA3157428A1 (en) 2019-12-19 2021-06-24 Universite De Strasbourg Sigma-1 receptor ligands and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1321153A (en) * 1999-07-01 2001-11-07 杰龙公司 Telomerase inhibitors and method of their use
GB0021421D0 (en) * 2000-08-31 2000-10-18 Oxford Glycosciences Uk Ltd Compounds

Also Published As

Publication number Publication date
WO2003070239A1 (en) 2003-08-28
AU2003214367A1 (en) 2003-09-09

Similar Documents

Publication Publication Date Title
GB0202216D0 (en) Novel compounds
GB0205256D0 (en) Novel compounds
GB0202679D0 (en) Novel compounds
GB0206723D0 (en) Novel compounds
GB0207249D0 (en) Novel compounds
GB0207246D0 (en) Novel compounds
GB0203299D0 (en) Novel compounds
GB0200025D0 (en) Novel compounds
GB0204252D0 (en) Novel compounds
GB0206196D0 (en) Novel compounds
GB0203902D0 (en) Novel compounds
GB0207278D0 (en) Novel compounds
GB0207275D0 (en) Novel compounds
GB0207282D0 (en) Novel compounds
GB0207283D0 (en) Novel compounds
GB0201357D0 (en) Novel compounds
GB0206716D0 (en) Novel compounds
GB0206714D0 (en) Novel compounds
GB0206612D0 (en) Novel compounds
GB0206610D0 (en) Novel compounds
GB0206201D0 (en) Novel compounds
GB0206198D0 (en) Novel compounds
GB0206197D0 (en) Novel compounds
GB0202217D0 (en) Novel compounds
GB0200108D0 (en) Novel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)